Researchers from MedInsight Research Institute analyze studies detailing gadolinium toxicity mechanisms, contradicting the longstanding belief that patients with normal kidney function are not at risk. The study calls for FDA action to address the gap in scientific knowledge about treatment for gadolinium toxicity.
Researchers found a maximum reduction of 52.4% in dry-eye symptoms using the repurposed drug, with some patients reporting complete resolution of symptoms. The treatment has antiangiogenic effects and offers distinct advantages over existing surgical removal methods.
LDNscience.org offers comprehensive information on low dose naltrexone (LDN) for patients with autoimmune diseases and chronic conditions. The revamped website provides resources, research, and educational materials to support treatment and quality of life.
Researchers have discovered that pre-treating mice with noscapine before injecting them with prostate cancer cells resulted in tumor growth rates being two-thirds smaller and lung metastasis rates being 80% less. The study suggests that noscapine may offer significant benefits in the management of prostate cancer as a preventive measure.
Researchers discovered that noscapine, an ingredient in common cough medication, reduced tumor growth by 60% and limited tumor spread by 65% without causing side effects. The findings suggest a promising treatment for advanced prostate cancer.